Clinical Trial: Assessment of Anti-inflammatory Markers Concentration, Effectiveness and Safety After Spinal Mesotherapy in Chronic Cervical Pain Syndrome

U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT06807177) titled 'Assessment of Anti-inflammatory Markers Concentration, Effectiveness and Safety After Spinal Mesotherapy in Chronic Cervical Pain Syndrome' on Jan. 29.

Brief Summary: The aim of the study is to assess the concentration of anti-inflammatory markers after the use of cervical spine mesotherapy in the course of pain syndrome. The study is randomized. Patients will be divided into two groups: A - mesotherapy using injectable type I collagen, B - mesotherapy using 1% lignocaine. The mesotherapy procedure will be performed five times, at weekly intervals. Blood will be collected before the start of mesotherapy, a week after its completion a...